Cell Expansion Market

Report Code BT 2850
Published in Mar, 2024, By MarketsandMarkets™
Download PDF

Choose License Type

Buy Report Now Inquire Before Buying

Cell Expansion Market by Product (Consumables (Media, Sera, Reagents, Vessels), Equipment (Cell Expansion Systems, Bioreactors, Incubators)), Cell Type (Human, Animal (CHO, mESCs)), Application (Vaccines, mAbs, CGT), End User - Global Forecast to 2029

Overview

The global cell expansion market in terms of revenue was estimated to be worth $14.3 billion in 2024 and is poised to reach $26.7 billion by 2029, growing at a CAGR of 13.3% from 2024 to 2029. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market. Growth of the cell expansion market can be attributed to factors such as the booming biopharmaceutical industry, increased investments in research and development for the advancement of biopharmaceutical industry, rising need of advanced biopharmaceuticals, and increasing GMP certification for cell therapy manufacturing facilities. However, ethical concern for cell based research and high cost of cell & gene therapy may hamper the growth of the market.

Attractive Opportunities in the Cell Expansion Market

Asia Pacific

The growth of the Asia Pacific cell expansion market is primarily due to growing need of cell based therapies, rising incidence of chronic diseases, increasing research activities for the advancement of biotechnology industry.

Growth in this market is primarily driven by the increasing investments and fundings in cell-based research, growing focus on personalized medicine , rising prevalence of chronic diseases.

Growing opportunities in emerging economies and advances in 3D cell expansion technology is likely to offer potential growth opportunities in the cell expansion market.

Ethical concern regarding cell biology is restraining the market growth.

The Asia Pacific market is estimated to grow at the highest CAGR during the forecast period.

Global Cell Expansion Market Dynamics

DRIVER: Increasing rate of chronic diseases

The increasing rate of chronic diseases is propelling the demand for advanced drug therapy products, resulting to boost the growth of cell expansion market. With an aging population, the prevalence of chronic diseases like cancer and diabetes is increasing, this has led to a higher demand for cell-based therapies, driving the need for cell expansion technologies. For instance, according to the American Cancer Society, there were an estimated 1.9 million new cancer cases and 609,360 cancer deaths reported in the US in 2022. Furthermore, Major companies are investing heavily in R&D to improve therapeutics and to meet the growing demand for cellular therapies which is supporting the growth of cell expansion market. Additionally, advancements in automation and bioprocessing technologies are propelling the growth of cell expansion market.

RESTRAINT: Ethical concern related to cell biology

Ethical concerns in cell biology pose a significant restraint on the cell expansion market. One major concern is the use of embryonic stem cells, which raises ethical concern about the destruction of human embryos. This has led to restrictions on the use of embryonic stem cells in many countries, limiting their availability for research and therapeutic applications. Another ethical issue is related to the sourcing of cells for expansion. While adult stem cells offer an ethical alternative to embryonic stem cells, their extraction often involves invasive procedures, raising concerns about patient consent and safety. Additionally, there are ethical considerations surrounding the use of genetically modified cells and potential risks to both patients and the environment. Thus, ethical concern regarding cell biology is hindering the growth of cell expansion market.

 

OPPORTUNITY: Growth opportunities in emerging economies

Emerging countries such as China, India, Brazil, and Mexico are expected to show significant growth opportunities for players operating in the cell expansion market driven by factors such as rising healthcare expenditure, expanding manufacturing capabilities, growing biopharmaceutical sector, technological advancements, expansion of key market players, and rising government support. By leveraging these opportunities, major market players are expanding their footprints in emerging economies and contribute to improving access to quality healthcare products across the globe.

CHALLENGE: Issues related to supply chain and logistics

Supply chain and logistics pose significant challenges for the cell expansion market. One major issue is the complex and fragile nature of cell-based products, which require stringent temperature control and specialized handling throughout the supply chain. Additionally, the global nature of the cell expansion market presents logistical challenges related to international shipping and regulatory compliance. Government regulations vary across regions, requiring companies to navigate complex import or export procedures and documentation requirements. Delays in customs clearance and regulatory approvals can disrupt supply chains and impact the timely delivery of cell-based therapies to patients.

Global Cell Expansion Market Ecosystem Analysis

Market Ecosystem Analysis The cell expansion market ecosystem comprises raw material suppliers, cell expansion product manufacturers, and end users such as pharmaceutical and biotechnology companies, research & academic institutes, hospitals & diagnostic laboratories, CROs, CDMOs, and cell banks. Cell expansion products manufacturers provide consumables including media, reagents, sera, vessels, and other consumables, and equipment such as bioreactors, automated cell expansion systems, and other cell expansion equipment.

 

The human cells segment dominated cell expansion industry in 2023

Based on cell type, the cell expansion market is segmented into three major segments, namely, human cells, animal cells, and other cell types. In 2023, human cells segment dominated the market owing to rising research activities for the development of cell based therapeutics such as regenerative medicine and cell & gene therapies. Moreover, rising R&D spendings by the government and major market players are propelling the adoption of human cells for manufacturing of cell based therapeutics, resulting to drive the segment growth in cell expansion market.

The pharmecutical & biotechnology companies segment dominated the cell expansion industry in 2023

Based on end user, the cell expansion market is segmented into pharmaceutical & biotechnology companies, research & academic institutes, hospitals & clinics, and other end users. In 2023, pharmaceutical & biotechnology companies segment held the largest market share in the global market owing to rising demand for manufacturing of novel therapeutics. Futher, growing focus on personalized medicine is promoting the segment growth is cell expansion market.

North America Region Holds the Largest share of the Cell Expansion Market

The global cell expansion market is segmented into six major regions—North America, Europe, the Asia Pacific, Latin America, Middle East, and Africa. North America accounted for the largest of cell expansion market in 2023, followed by Europe and the Asia Pacific. Factors such as significant expenditure on R&D activities, presence of a well-established healthcare market, growing demand for cell based therapeutics, among others are responsible for the largest share of this segment.

 
 

Recent Developments of Cell Expansion Market industry

  • In April 2023, Danaher Corporation (Cytiva) launched X-platform bioreactors to simplify single-use upstream bioprocessing operations. The X-platform bioreactors can be used to manufacture monoclonal antibodies, cell & gene therapies, and viral vectors. The bioreactors are customizable and scalable and are expected to increase productivity in process development and manufacturing.
  • In December 2022, Merck acquired Erbi Biosystems, a developer of the 2 ml micro-bioreactor platform technology, known as the Breez. The acquisition aims to strengthens Merck’s upstream portfolio in therapeutic proteins by enabling scalable cell-based perfusion bioreactor processes from 2ml to 2000L with rapid lab-scale process development.

Key Market Players

Want to explore hidden markets that can drive new revenue in Cell Expansion Market?

Scope of the Report

Report Attribute Details
Market Revenue in 2024 $14.3 billion
Projected Revenue by 2029 $26.7 billion
Revenue Rate Poised to Grow at a CAGR of 13.3%
Market Driver Increasing rate of chronic diseases
Market Opportunity Growth opportunities in emerging economies

 

Key Questions Addressed by the Report

What is the projected market revenue value of the global cell expansion market?
The global cell expansion market boasts a total revenue value of $26.7 billion by 2029.
What is the estimated growth rate (CAGR) of the global cell expansion market?
The global cell expansion market has an estimated compound annual growth rate (CAGR) of 13.3% and a revenue size in the region of $14.3 billion in 2024

 

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Cell Expansion Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request

Table of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
INTRODUCTION
51
RESEARCH METHODOLOGY
58
EXECUTIVE SUMMARY
69
PREMIUM INSIGHTS
73
MARKET OVERVIEW
76
  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    DRIVERS
    - Increasing incidence of chronic diseases
    - Rising government investments in cell-based research and therapies
    - Growing focus on personalized medicine
    - Increasing GMP certifications for cell therapy production facilities
    - Growing strategic alliances for development of cell-based therapeutics
    RESTRAINTS
    - Ethical concerns regarding research in cell biology
    - High cost of cell-based therapies
    OPPORTUNITIES
    - High growth opportunities in emerging markets
    - Growing utility of 3D cell expansion technology
    - Growing automation in cell therapy manufacturing
    CHALLENGES
    - Concerns regarding supply chain logistics
    - Challenges related to scale-up of cell and gene therapies
  • 5.3 TECHNOLOGY ANALYSIS
    KEY TECHNOLOGIES
    - Single-use technology
    - Automated cell expansion
    COMPLEMENTARY TECHNOLOGIES
    - High-throughput screening
    - Single-cell analysis
    ADJACENT TECHNOLOGIES
    - Microfluidics and organ-on-a-chip
    - 3D bioprinting
  • 5.4 TRADE DATA
  • 5.5 SUPPLY CHAIN ANALYSIS
  • 5.6 VALUE CHAIN ANALYSIS
  • 5.7 PRICING ANALYSIS
  • 5.8 ECOSYSTEM ANALYSIS
    RAW MATERIAL VENDORS IN CELL EXPANSION MARKET
    PRODUCT VENDORS IN CELL EXPANSION MARKET
    END USERS IN CELL EXPANSION MARKET
    REGULATORY BODIES GOVERNING CELL EXPANSION MARKET
  • 5.9 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS
  • 5.10 PATENT ANALYSIS
    METHODOLOGY
    PATENTS FILED, BY DOCUMENT TYPE, 2014–2024
    INNOVATION AND PATENT APPLICATIONS
    TOP APPLICANTS
  • 5.11 KEY CONFERENCES AND EVENTS
  • 5.12 REGULATORY LANDSCAPE
    REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    REGULATORY SCENARIO
  • 5.13 PORTER’S FIVE FORCES ANALYSIS
    THREAT OF NEW ENTRANTS
    THREAT OF SUBSTITUTES
    BARGAINING POWER OF SUPPLIERS
    BARGAINING POWER OF BUYERS
    INTENSITY OF COMPETITIVE RIVALRY
  • 5.14 KEY STAKEHOLDERS AND BUYING CRITERIA
    KEY STAKEHOLDERS IN BUYING PROCESS
    ROLE OF STAKEHOLDERS IN BUYING PROCESS
    BUYING CRITERIA FOR CELL EXPANSION MARKET
  • 5.15 INVESTMENT/FUNDING ACTIVITIES
CELL EXPANSION MARKET, BY PRODUCT
125
  • 6.1 INTRODUCTION
  • 6.2 CONSUMABLES
    MEDIA
    - Serum-free media
    - Classical media & salts
    - Stem cell culture media
    - Chemically defined media
    - Specialty media
    - Other media types
    REAGENTS
    - Rising need for unique signaling molecules for cell proliferation to boost growth
    SERA
    - Growing R&D activities to drive demand for sera
    VESSELS
    - Roller/roux bottles
    - Cell factory systems/cell stacks
    - Flasks
    - Multiwell plates
    - Cell expansion bags
    - Petri dishes
    OTHER CONSUMABLES
  • 6.3 EQUIPMENT
    BIOREACTORS
    - Bioreactors, by Usage
    - Bioreactors, by Type
    AUTOMATED CELL EXPANSION SYSTEMS
    - Increasing automation in cell & gene therapy manufacturing to boost demand
    OTHER CELL EXPANSION EQUIPMENT
CELL EXPANSION MARKET, BY CELL TYPE
207
  • 7.1 INTRODUCTION
  • 7.2 HUMAN CELLS
    STEM CELLS
    - Adult stem cells
    - Embryonic stem cells
    - Induced pluripotent stem cells
    DIFFERENTIATED CELLS
    - Increasing research activities to drive growth
  • 7.3 ANIMAL CELLS
    CHINESE HAMSTER OVARY CELLS
    - Growing strategic alliances for development of novel biopharmaceuticals to drive growth
    MOUSE EMBRYONIC STEM CELLS
    - Growing research activities to develop innovative therapies to support market growth
    OTHER ANIMAL CELLS
  • 7.4 OTHER CELL TYPES
CELL EXPANSION MARKET, BY APPLICATION
243
  • 8.1 INTRODUCTION
  • 8.2 BIOPHARMACEUTICAL PRODUCTION
    MONOCLONAL ANTIBODY PRODUCTION
    - Increasing regulatory approvals for mAb treatments to drive growth
    VACCINE PRODUCTION
    - Rising incidence of infectious diseases to drive growth
    OTHER THERAPEUTIC PROTEIN PRODUCTION
  • 8.3 TISSUE ENGINEERING & REGENERATIVE MEDICINE
    CELL & GENE THERAPY
    - Increasing investments in cell-based therapies to drive market
    OTHER TISSUE ENGINEERING & REGENERATIVE MEDICINE APPLICATIONS
  • 8.4 DRUG SCREENING & DEVELOPMENT
    INCREASING DEMAND FOR NOVEL THERAPEUTICS TO SUPPORT MARKET GROWTH
  • 8.5 OTHER APPLICATIONS
CELL EXPANSION MARKET, BY END USER
272
  • 9.1 INTRODUCTION
  • 9.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
    GROWING STRATEGIC ALLIANCES BY KEY MARKET PLAYERS TO DRIVE GROWTH
  • 9.3 RESEARCH & ACADEMIC INSTITUTES
    INCREASING GOVERNMENT FUNDING FOR CELL-BASED RESEARCH TO DRIVE MARKET
  • 9.4 HOSPITALS & DIAGNOSTIC LABORATORIES
    GROWING DEMAND FOR CELL-BASED THERAPIES TO PROPEL MARKET
  • 9.5 OTHER END USERS
CELL EXPANSION MARKET, BY REGION
286
  • 10.1 INTRODUCTION
  • 10.2 NORTH AMERICA
    US
    - Rising investments in cell-based research to drive market
    CANADA
    - Growing funding for advancement of regenerative medicine to support market growth
    NORTH AMERICA: RECESSION IMPACT
  • 10.3 EUROPE
    GERMANY
    - Increasing number of strategic alliances for development of cell-based therapies to drive market
    UK
    - Increasing focus on advancement of regenerative medicine to propel market
    FRANCE
    - Growing strategic alliances for development of advanced cell and gene therapies to support market growth
    ITALY
    - Increased focus on life sciences R&D activities and growing biotech industry to drive market
    SPAIN
    - Expansion of biotech companies to support market growth
    REST OF EUROPE
    EUROPE: RECESSION IMPACT
  • 10.4 ASIA PACIFIC
    CHINA
    - Increasing R&D expenditure and rising number of clinical trials for novel therapeutics to propel market
    JAPAN
    - Rising investments for advancement of biotechnology sector to boost market growth
    INDIA
    - Rising funding to boost biopharmaceutical sector and growing focus on development of cell-based therapies to propel market
    SOUTH KOREA
    - Growing strategic alliances and investments in research to drive market
    AUSTRALIA
    - Growing life science sector to drive market
    REST OF ASIA PACIFIC
    ASIA PACIFIC: RECESSION IMPACT
  • 10.5 LATIN AMERICA
    BRAZIL
    - Increasing demand for biopharmaceuticals to drive market
    MEXICO
    - Increasing government support for biopharmaceutical production to support market growth
    REST OF LATIN AMERICA
    LATIN AMERICA: RECESSION IMPACT
  • 10.6 MIDDLE EAST
    GCC COUNTRIES
    - Saudi Arabia
    - United Arab Emirates
    - Rest of GCC countries
    REST OF THE MIDDLE EAST
    MIDDLE EAST: RECESSION IMPACT
  • 10.7 AFRICA
    RISING FUNDING ACTIVITIES FOR BIOPHARMA AND CELL & GENE THERAPY TO FUEL MARKET GROWTH
    AFRICA: RECESSION IMPACT
COMPETITIVE LANDSCAPE
455
  • 11.1 OVERVIEW
  • 11.2 STRATEGIES ADOPTED BY KEY PLAYERS/RIGHT TO WIN
  • 11.3 REVENUE SHARE ANALYSIS
  • 11.4 MARKET SHARE ANALYSIS
  • 11.5 BRAND/PRODUCT COMPARATIVE ANALYSIS
  • 11.6 COMPANY EVALUATION MATRIX: KEY PLAYERS
    STARS
    EMERGING LEADERS
    PERVASIVE PLAYERS
    PARTICIPANTS
  • 11.7 COMPANY FOOTPRINT: KEY PLAYERS
    COMPANY FOOTPRINT
    REGIONAL FOOTPRINT
    PRODUCT FOOTPRINT
    APPLICATION FOOTPRINT
    END-USER FOOTPRINT
  • 11.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES
    PROGRESSIVE COMPANIES
    STARTING BLOCKS
    RESPONSIVE COMPANIES
    DYNAMIC COMPANIES
    COMPETITIVE BENCHMARKING: STARTUPS/SMES
  • 11.9 VALUATION AND FINANCIAL METRICS OF CELL EXPANSION VENDORS
  • 11.10 COMPETITIVE SCENARIO
    PRODUCT LAUNCHES
    DEALS
    EXPANSIONS
COMPANY PROFILES
476
  • 12.1 INTRODUCTION
  • 12.2 KEY PLAYERS
    THERMO FISHER SCIENTIFIC INC.
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    DANAHER CORPORATION
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    MERCK KGAA
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    SARTORIUS AG
    - Business overview
    - Products offered
    - Recent developments
    CORNING INCORPORATED
    - Business overview
    - Products offered
    - Recent developments
    LONZA
    - Business overview
    - Products offered
    - Recent developments
    TERUMO CORPORATION
    - Business overview
    - Products offered
    - Recent developments
    EPPENDORF SE
    - Business overview
    - Products offered
    - Recent developments
    FUJIFILM CORPORATION
    - Business overview
    - Products offered
    - Recent developments
    BIO-TECHNE
    - Business overview
    - Products offered
    - Recent developments
    REPLIGEN CORPORATION
    - Business overview
    - Products offered
    - Recent developments
    GETINGE AB
    - Business overview
    - Products offered
    - Recent developments
    BD
    - Business overview
    - Products offered
    MILTENYI BIOTEC
    - Business overview
    - Products offered
    - Recent developments
    PERKINELMER INC.
    - Business overview
    - Products offered
    - Recent developments
    STEMCELL TECHNOLOGIES
    - Business overview
    - Products offered
    - Recent developments
    PROMOCELL GMBH
    - Business overview
    - Products offered
    - Recent developments
    HIMEDIA LABORATORIES
    - Business overview
    - Products offered
  • 12.3 OTHER PLAYERS
    TAKARA BIO INC.
    SHANGHAI DUONING BIOTECHNOLOGY CO., LTD.
    REPROCELL INC.
    ACROBIOSYSTEMS
    SOLIDA BIOTECH GMBH
    BEIJING CYTONICHE BIOTECHNOLOGY CO., LTD.
    NEUROMICS
    BIONET
    CELLEXUS
APPENDIX
586
  • 13.1 DISCUSSION GUIDE
  • 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
  • 13.3 CUSTOMIZATION OPTIONS
  • 13.4 RELATED REPORTS
  • 13.5 AUTHOR DETAILS
LIST OF TABLES
 
  • TABLE 1 FACTOR ANALYSIS
  • TABLE 2 CELL EXPANSION MARKET: IMPACT ANALYSIS
  • TABLE 3 STRATEGIC ALLIANCES IN CELL-BASED THERAPEUTICS
  • TABLE 4 ADVANTAGES OF SINGLE-USE BIOREACTORS AND CONVENTIONAL BIOREACTORS
  • TABLE 5 IMPORT VALUE FOR CELL CULTURE MEDIA, 2018–2022 (USD THOUSAND)
  • TABLE 6 EXPORT VALUE FOR CELL CULTURE MEDIA, 2018–2022 (USD THOUSAND)
  • TABLE 7 IMPORT VOLUME FOR CELL CULTURE MEDIA, 2018–2022 (TONS)
  • TABLE 8 EXPORT VOLUME FOR CELL CULTURE MEDIA, 2018–2022 (TONS)
  • TABLE 9 AVERAGE SELLING PRICE OF CELL EXPANSION PRODUCTS
  • TABLE 10 AVERAGE SELLING PRICE OF CELL EXPANSION PRODUCTS, BY REGION
  • TABLE 11 CELL CULTURE MARKET: ROLE OF RAW MATERIAL VENDORS
  • TABLE 12 CELL EXPANSION MARKET: ROLE OF PRODUCT VENDORS
  • TABLE 13 CELL EXPANSION MARKET: ROLE OF END USERS
  • TABLE 14 CELL EXPANSION MARKET: ROLE OF REGULATORY BODIES
  • TABLE 15 PATENTS FILED, 2014–2024
  • TABLE 16 TOP 20 PATENT OWNERS IN CELL EXPANSION MARKET, 2014–2024
  • TABLE 17 PATENTS IN CELL EXPANSION MARKET, 2024
  • TABLE 18 CELL EXPANSION MARKET: KEY CONFERENCES AND EVENTS, 2024–2025
  • TABLE 19 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 20 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 21 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 22 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 23 CELL EXPANSION MARKET: REGULATORY GUIDELINES
  • TABLE 24 CELL EXPANSION MARKET: PORTER’S FIVE FORCES ANALYSIS
  • TABLE 25 BUYING CRITERIA FOR CELL EXPANSION PRODUCTS, BY END USER
  • TABLE 26 CELL EXPANSION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 27 CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 28 CONSUMABLES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 29 NORTH AMERICA: CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 30 EUROPE: CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 31 ASIA PACIFIC: CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 32 LATIN AMERICA: CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 33 MIDDLE EAST: CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 34 GCC COUNTRIES: CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 35 MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 36 MEDIA MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 37 NORTH AMERICA: MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 38 EUROPE: MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 39 ASIA PACIFIC: MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 40 LATIN AMERICA: MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 41 MIDDLE EAST: MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 42 GCC COUNTRIES: MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 43 SERUM-FREE MEDIA MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 44 NORTH AMERICA: SERUM-FREE MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 45 EUROPE: SERUM-FREE MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 46 ASIA PACIFIC: SERUM-FREE MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 47 LATIN AMERICA: SERUM-FREE MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 48 MIDDLE EAST: SERUM-FREE MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 49 GCC COUNTRIES: SERUM-FREE MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 50 CLASSICAL MEDIA & SALTS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 51 NORTH AMERICA: CLASSICAL MEDIA & SALTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 52 EUROPE: CLASSICAL MEDIA & SALTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 53 ASIA PACIFIC: CLASSICAL MEDIA & SALTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 54 LATIN AMERICA: CLASSICAL MEDIA & SALTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 55 MIDDLE EAST: CLASSICAL MEDIA & SALTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 56 GCC COUNTRIES: CLASSICAL MEDIA & SALTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 57 STEM CELL CULTURE MEDIA MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 58 NORTH AMERICA: STEM CELL CULTURE MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 59 EUROPE: STEM CELL CULTURE MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 60 ASIA PACIFIC: STEM CELL CULTURE MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 61 LATIN AMERICA: STEM CELL CULTURE MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 62 MIDDLE EAST: STEM CELL CULTURE MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 63 GCC COUNTRIES: STEM CELL CULTURE MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 64 CHEMICALLY DEFINED MEDIA MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 65 NORTH AMERICA: CHEMICALLY DEFINED MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 66 EUROPE: CHEMICALLY DEFINED MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 67 ASIA PACIFIC: CHEMICALLY DEFINED MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 68 LATIN AMERICA: CHEMICALLY DEFINED MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 69 MIDDLE EAST: CHEMICALLY DEFINED MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 70 GCC COUNTRIES: CHEMICALLY DEFINED MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 71 EXAMPLES OF SPECIALTY MEDIA OFFERED BY KEY PLAYERS
  • TABLE 72 SPECIALTY MEDIA MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 73 NORTH AMERICA: SPECIALTY MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 74 EUROPE: SPECIALTY MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 75 ASIA PACIFIC: SPECIALTY MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 76 LATIN AMERICA: SPECIALTY MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 77 MIDDLE EAST: SPECIALTY MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 78 GCC COUNTRIES: SPECIALTY MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 79 OTHER MEDIA TYPES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 80 NORTH AMERICA: OTHER MEDIA TYPES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 81 EUROPE: OTHER MEDIA TYPES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 82 ASIA PACIFIC: OTHER MEDIA TYPES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 83 LATIN AMERICA: OTHER MEDIA TYPES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 84 MIDDLE EAST: OTHER MEDIA TYPES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 85 GCC COUNTRIES: OTHER MEDIA TYPES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 86 REAGENTS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 87 NORTH AMERICA: REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 88 EUROPE: REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 89 ASIA PACIFIC: REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 90 LATIN AMERICA: REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 91 MIDDLE EAST: REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 92 GCC COUNTRIES: REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 93 SERA MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 94 NORTH AMERICA: SERA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 95 EUROPE: SERA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 96 ASIA PACIFIC: SERA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 97 LATIN AMERICA: SERA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 98 MIDDLE EAST: SERA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 99 GCC COUNTRIES: SERA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 100 VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 101 VESSELS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 102 NORTH AMERICA: VESSELS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 103 EUROPE: VESSELS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 104 ASIA PACIFIC: VESSELS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 105 LATIN AMERICA: VESSELS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 106 MIDDLE EAST: VESSELS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 107 GCC COUNTRIES: VESSELS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 108 ROLLER/ROUX BOTTLES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 109 NORTH AMERICA: ROLLER/ROUX BOTTLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 110 EUROPE: ROLLER/ROUX BOTTLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 111 ASIA PACIFIC ROLLER/ROUX BOTTLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 112 LATIN AMERICA: ROLLER/ROUX BOTTLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 113 MIDDLE EAST: ROLLER/ROUX BOTTLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 114 GCC COUNTRIES: ROLLER/ROUX BOTTLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 115 CELL FACTORY SYSTEMS/CELL STACKS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 116 NORTH AMERICA: CELL FACTORY SYSTEMS/CELL STACKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 117 EUROPE: CELL FACTORY SYSTEMS/CELL STACKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 118 ASIA PACIFIC: CELL FACTORY SYSTEMS/CELL STACKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 119 LATIN AMERICA: CELL FACTORY SYSTEMS/CELL STACKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 120 MIDDLE EAST: CELL FACTORY SYSTEMS/CELL STACKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 121 GCC COUNTRIES: CELL FACTORY SYSTEMS/CELL STACKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 122 FLASKS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 123 NORTH AMERICA: FLASKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 124 EUROPE: FLASKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 125 ASIA PACIFIC: FLASKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 126 LATIN AMERICA: FLASKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 127 MIDDLE EAST: FLASKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 128 GCC COUNTRIES: FLASKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 129 MULTIWELL PLATES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 130 NORTH AMERICA: MULTIWELL PLATES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 131 EUROPE: MULTIWELL PLATES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 132 ASIA PACIFIC: MULTIWELL PLATES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 133 LATIN AMERICA: MULTIWELL PLATES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 134 MIDDLE EAST: MULTIWELL PLATES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 135 GCC COUNTRIES: MULTIWELL PLATES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 136 CELL EXPANSION BAGS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 137 NORTH AMERICA: CELL EXPANSION BAGS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 138 EUROPE: CELL EXPANSION BAGS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 139 ASIA PACIFIC: CELL EXPANSION BAGS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 140 LATIN AMERICA: CELL EXPANSION BAGS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 141 MIDDLE EAST: CELL EXPANSION BAGS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 142 GCC COUNTRIES: CELL EXPANSION BAGS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 143 PETRI DISHES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 144 NORTH AMERICA: PETRI DISHES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 145 EUROPE: PETRI DISHES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 146 ASIA PACIFIC: PETRI DISHES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 147 LATIN AMERICA: PETRI DISHES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 148 MIDDLE EAST: PETRI DISHES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 149 GCC COUNTRIES: PETRI DISHES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 150 OTHER CONSUMABLES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 151 NORTH AMERICA: OTHER CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 152 EUROPE: OTHER CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 153 ASIA PACIFIC: OTHER CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 154 LATIN AMERICA: OTHER CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 155 MIDDLE EAST: OTHER CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 156 GCC COUNTRIES: OTHER CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 157 EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 158 EQUIPMENT MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 159 NORTH AMERICA: EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 160 EUROPE: EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 161 ASIA PACIFIC: EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 162 LATIN AMERICA: EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 163 MIDDLE EAST: EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 164 GCC COUNTRIES: EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 165 BIOREACTORS MARKET, BY USAGE, 2022–2029 (USD MILLION)
  • TABLE 166 BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 167 BIOREACTORS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 168 NORTH AMERICA: BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 169 EUROPE: BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 170 ASIA PACIFIC: BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 171 LATIN AMERICA: BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 172 MIDDLE EAST: BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 173 GCC COUNTRIES: BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 174 CONVENTIONAL BIOREACTORS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 175 NORTH AMERICA: CONVENTIONAL BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 176 EUROPE: CONVENTIONAL BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 177 ASIA PACIFIC: CONVENTIONAL BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 178 LATIN AMERICA: CONVENTIONAL BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 179 MIDDLE EAST: CONVENTIONAL BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 180 GCC COUNTRIES: CONVENTIONAL BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 181 SINGLE-USE BIOREACTORS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 182 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 183 EUROPE: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 184 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 185 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 186 MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 187 GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 188 MICROCARRIER BIOREACTORS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 189 NORTH AMERICA: MICROCARRIER BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 190 EUROPE: MICROCARRIER BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 191 ASIA PACIFIC: MICROCARRIER BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 192 LATIN AMERICA: MICROCARRIER BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 193 MIDDLE EAST: MICROCARRIER BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 194 GCC COUNTRIES: MICROCARRIER BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 195 SUSPENSION-BASED INDEPENDENT BIOREACTORS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 196 NORTH AMERICA: SUSPENSION-BASED INDEPENDENT BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 197 EUROPE: SUSPENSION-BASED INDEPENDENT BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 198 ASIA PACIFIC: SUSPENSION-BASED INDEPENDENT BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 199 LATIN AMERICA: SUSPENSION-BASED INDEPENDENT BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 200 MIDDLE EAST: SUSPENSION-BASED INDEPENDENT BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 201 GCC COUNTRIES: SUSPENSION-BASED INDEPENDENT BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 202 HOLLOW FIBER BIOREACTORS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 203 NORTH AMERICA: HOLLOW FIBER BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 204 EUROPE: HOLLOW FIBER BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 205 ASIA PACIFIC: HOLLOW FIBER BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 206 LATIN AMERICA: HOLLOW FIBER BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 207 MIDDLE EAST: HOLLOW FIBER BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 208 GCC COUNTRIES: HOLLOW FIBER BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 209 OTHER BIOREACTORS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 210 NORTH AMERICA: OTHER BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 211 EUROPE: OTHER BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 212 ASIA PACIFIC: OTHER BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 213 LATIN AMERICA: OTHER BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 214 MIDDLE EAST: OTHER BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 215 GCC COUNTRIES: OTHER BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 216 AUTOMATED CELL EXPANSION SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 217 NORTH AMERICA: AUTOMATED CELL EXPANSION SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 218 EUROPE: AUTOMATED CELL EXPANSION SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 219 ASIA PACIFIC: AUTOMATED CELL EXPANSION SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 220 LATIN AMERICA: AUTOMATED CELL EXPANSION SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 221 MIDDLE EAST: AUTOMATED CELL EXPANSION SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 222 GCC COUNTRIES: AUTOMATED CELL EXPANSION SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 223 OTHER CELL EXPANSION EQUIPMENT MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 224 NORTH AMERICA: OTHER CELL EXPANSION EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 225 EUROPE: OTHER CELL EXPANSION EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 226 ASIA PACIFIC: OTHER CELL EXPANSION EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 227 LATIN AMERICA: OTHER CELL EXPANSION EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 228 MIDDLE EAST: OTHER CELL EXPANSION EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 229 GCC COUNTRIES: OTHER CELL EXPANSION EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 230 CELL EXPANSION MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
  • TABLE 231 CELL EXPANSION MARKET FOR HUMAN CELLS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 232 CELL EXPANSION MARKET FOR HUMAN CELLS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 233 NORTH AMERICA: CELL EXPANSION MARKET FOR HUMAN CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 234 EUROPE: CELL EXPANSION MARKET FOR HUMAN CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 235 ASIA PACIFIC: CELL EXPANSION MARKET FOR HUMAN CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 236 LATIN AMERICA: CELL EXPANSION MARKET FOR HUMAN CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 237 MIDDLE EAST: CELL EXPANSION MARKET FOR HUMAN CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 238 GCC COUNTRIES: CELL EXPANSION MARKET FOR HUMAN CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 239 CELL EXPANSION MARKET FOR STEM CELLS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 240 CELL EXPANSION MARKET FOR STEM CELLS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 241 NORTH AMERICA: CELL EXPANSION MARKET FOR STEM CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 242 EUROPE: CELL EXPANSION MARKET FOR STEM CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 243 ASIA PACIFIC: CELL EXPANSION MARKET FOR STEM CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 244 LATIN AMERICA: CELL EXPANSION MARKET FOR STEM CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 245 MIDDLE EAST: CELL EXPANSION MARKET FOR STEM CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 246 GCC COUNTRIES: CELL EXPANSION MARKET FOR STEM CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 247 CELL EXPANSION MARKET FOR ADULT STEM CELLS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 248 NORTH AMERICA: CELL EXPANSION MARKET FOR ADULT STEM CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 249 EUROPE: CELL EXPANSION MARKET FOR ADULT STEM CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 250 ASIA PACIFIC: CELL EXPANSION MARKET FOR ADULT STEM CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 251 LATIN AMERICA: CELL EXPANSION MARKET FOR ADULT STEM CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 252 MIDDLE EAST: CELL EXPANSION MARKET FOR ADULT STEM CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 253 GCC COUNTRIES: CELL EXPANSION MARKET FOR ADULT STEM CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 254 CELL EXPANSION MARKET FOR EMBRYONIC STEM CELLS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 255 NORTH AMERICA: CELL EXPANSION MARKET FOR EMBRYONIC STEM CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 256 EUROPE: CELL EXPANSION MARKET FOR EMBRYONIC STEM CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 257 ASIA PACIFIC: CELL EXPANSION MARKET FOR EMBRYONIC STEM CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 258 LATIN AMERICA: CELL EXPANSION MARKET FOR EMBRYONIC STEM CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 259 MIDDLE EAST: CELL EXPANSION MARKET FOR EMBRYONIC STEM CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 260 GCC COUNTRIES: CELL EXPANSION MARKET FOR EMBRYONIC STEM CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 261 CELL EXPANSION MARKET FOR INDUCED PLURIPOTENT STEM CELLS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 262 NORTH AMERICA: CELL EXPANSION MARKET FOR INDUCED PLURIPOTENT STEM CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 263 EUROPE: CELL EXPANSION MARKET FOR INDUCED PLURIPOTENT STEM CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 264 ASIA PACIFIC: CELL EXPANSION MARKET FOR INDUCED PLURIPOTENT STEM CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 265 LATIN AMERICA: CELL EXPANSION MARKET FOR INDUCED PLURIPOTENT STEM CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 266 MIDDLE EAST: CELL EXPANSION MARKET FOR INDUCED PLURIPOTENT STEM CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 267 GCC COUNTRIES: CELL EXPANSION MARKET FOR INDUCED PLURIPOTENT STEM CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 268 CELL EXPANSION MARKET FOR DIFFERENTIATED CELLS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 269 NORTH AMERICA: CELL EXPANSION MARKET FOR DIFFERENTIATED CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 270 EUROPE: CELL EXPANSION MARKET FOR DIFFERENTIATED CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 271 ASIA PACIFIC: CELL EXPANSION MARKET FOR DIFFERENTIATED CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 272 LATIN AMERICA: CELL EXPANSION MARKET FOR DIFFERENTIATED CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 273 MIDDLE EAST: CELL EXPANSION MARKET FOR DIFFERENTIATED CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 274 GCC COUNTRIES: CELL EXPANSION MARKET FOR DIFFERENTIATED CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 275 CELL EXPANSION MARKET FOR ANIMAL CELLS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 276 CELL EXPANSION MARKET FOR ANIMAL CELLS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 277 NORTH AMERICA: CELL EXPANSION MARKET FOR ANIMAL CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 278 EUROPE: CELL EXPANSION MARKET FOR ANIMAL CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 279 ASIA PACIFIC: CELL EXPANSION MARKET FOR ANIMAL CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 280 LATIN AMERICA: CELL EXPANSION MARKET FOR ANIMAL CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 281 MIDDLE EAST: CELL EXPANSION MARKET FOR ANIMAL CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 282 GCC COUNTRIES: CELL EXPANSION MARKET FOR ANIMAL CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 283 CELL EXPANSION MARKET FOR CHINESE HAMSTER OVARY CELLS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 284 NORTH AMERICA: CELL EXPANSION MARKET FOR CHINESE HAMSTER OVARY CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 285 EUROPE: CELL EXPANSION MARKET FOR CHINESE HAMSTER OVARY CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 286 ASIA PACIFIC: CELL EXPANSION MARKET FOR CHINESE HAMSTER OVARY CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 287 LATIN AMERICA: CELL EXPANSION MARKET FOR CHINESE HAMSTER OVARY CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 288 MIDDLE EAST: CELL EXPANSION MARKET FOR CHINESE HAMSTER OVARY CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 289 GCC COUNTRIES: CELL EXPANSION MARKET FOR CHINESE HAMSTER OVARY CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 290 CELL EXPANSION MARKET FOR MOUSE EMBRYONIC STEM CELLS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 291 NORTH AMERICA: CELL EXPANSION MARKET FOR MOUSE EMBRYONIC STEM CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 292 EUROPE: CELL EXPANSION MARKET FOR MOUSE EMBRYONIC STEM CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 293 ASIA PACIFIC: CELL EXPANSION MARKET FOR MOUSE EMBRYONIC STEM CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 294 LATIN AMERICA: CELL EXPANSION MARKET FOR MOUSE EMBRYONIC STEM CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 295 MIDDLE EAST: CELL EXPANSION MARKET FOR MOUSE EMBRYONIC STEM CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 296 GCC COUNTRIES: CELL EXPANSION MARKET FOR MOUSE EMBRYONIC STEM CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 297 CELL EXPANSION MARKET FOR OTHER ANIMAL CELLS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 298 NORTH AMERICA: CELL EXPANSION MARKET FOR OTHER ANIMAL CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 299 EUROPE: CELL EXPANSION MARKET FOR OTHER ANIMAL CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 300 ASIA PACIFIC: CELL EXPANSION MARKET FOR OTHER ANIMAL CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 301 LATIN AMERICA: CELL EXPANSION MARKET FOR OTHER ANIMAL CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 302 MIDDLE EAST: CELL EXPANSION MARKET FOR OTHER ANIMAL CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 303 GCC COUNTRIES: CELL EXPANSION MARKET FOR OTHER ANIMAL CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 304 CELL EXPANSION MARKET FOR OTHER CELL TYPES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 305 NORTH AMERICA: CELL EXPANSION MARKET FOR OTHER CELL TYPES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 306 EUROPE: CELL EXPANSION MARKET FOR OTHER CELL TYPES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 307 ASIA PACIFIC: CELL EXPANSION MARKET FOR OTHER CELL TYPES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 308 LATIN AMERICA: CELL EXPANSION MARKET FOR OTHER CELL TYPES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 309 MIDDLE EAST: CELL EXPANSION MARKET FOR OTHER CELL TYPES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 310 GCC COUNTRIES: CELL EXPANSION MARKET FOR OTHER CELL TYPES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 311 CELL EXPANSION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 312 CELL EXPANSION MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 313 CELL EXPANSION MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 314 NORTH AMERICA: CELL EXPANSION MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 315 EUROPE: CELL EXPANSION MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 316 ASIA PACIFIC: CELL EXPANSION MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 317 LATIN AMERICA: CELL EXPANSION MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 318 MIDDLE EAST: CELL EXPANSION MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 319 GCC COUNTRIES: CELL EXPANSION MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 320 CELL EXPANSION MARKET FOR MONOCLONAL ANTIBODY PRODUCTION, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 321 NORTH AMERICA: CELL EXPANSION MARKET FOR MONOCLONAL ANTIBODY PRODUCTION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 322 EUROPE: CELL EXPANSION MARKET FOR MONOCLONAL ANTIBODY PRODUCTION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 323 ASIA PACIFIC: CELL EXPANSION MARKET FOR MONOCLONAL ANTIBODY PRODUCTION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 324 LATIN AMERICA: CELL EXPANSION MARKET FOR MONOCLONAL ANTIBODY PRODUCTION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 325 MIDDLE EAST: CELL EXPANSION MARKET FOR MONOCLONAL ANTIBODY PRODUCTION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 326 GCC COUNTRIES: CELL EXPANSION MARKET FOR MONOCLONAL ANTIBODY PRODUCTION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 327 CELL EXPANSION MARKET FOR VACCINE PRODUCTION, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 328 NORTH AMERICA: CELL EXPANSION MARKET FOR VACCINE PRODUCTION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 329 EUROPE: CELL EXPANSION MARKET FOR VACCINE PRODUCTION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 330 ASIA PACIFIC: CELL EXPANSION MARKET FOR VACCINE PRODUCTION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 331 LATIN AMERICA: CELL EXPANSION MARKET FOR VACCINE PRODUCTION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 332 MIDDLE EAST: CELL EXPANSION MARKET FOR VACCINE PRODUCTION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 333 GCC COUNTRIES: CELL EXPANSION MARKET FOR VACCINE PRODUCTION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 334 CELL EXPANSION MARKET FOR OTHER THERAPEUTIC PROTEIN PRODUCTION, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 335 NORTH AMERICA: CELL EXPANSION MARKET FOR OTHER THERAPEUTIC PROTEIN PRODUCTION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 336 EUROPE: CELL EXPANSION MARKET FOR OTHER THERAPEUTIC PROTEIN PRODUCTION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 337 ASIA PACIFIC: CELL EXPANSION MARKET FOR OTHER THERAPEUTIC PROTEIN PRODUCTION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 338 LATIN AMERICA: CELL EXPANSION MARKET FOR OTHER THERAPEUTIC PROTEIN PRODUCTION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 339 MIDDLE EAST: CELL EXPANSION MARKET FOR OTHER THERAPEUTIC PROTEIN PRODUCTION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 340 GCC COUNTRIES: CELL EXPANSION MARKET FOR OTHER THERAPEUTIC PROTEIN PRODUCTION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 341 CELL EXPANSION MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 342 CELL EXPANSION MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 343 NORTH AMERICA: CELL EXPANSION MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 344 EUROPE: CELL EXPANSION MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 345 ASIA PACIFIC: CELL EXPANSION MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 346 LATIN AMERICA: CELL EXPANSION MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 347 MIDDLE EAST: CELL EXPANSION MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 348 GCC COUNTRIES: CELL EXPANSION MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 349 CELL EXPANSION MARKET FOR CELL & GENE THERAPY, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 350 NORTH AMERICA: CELL EXPANSION MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 351 EUROPE: CELL EXPANSION MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 352 ASIA PACIFIC: CELL EXPANSION MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 353 LATIN AMERICA: CELL EXPANSION MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 354 MIDDLE EAST: CELL EXPANSION MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 355 GCC COUNTRIES: CELL EXPANSION MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 356 CELL EXPANSION MARKET FOR OTHER TISSUE ENGINEERING & REGENERATIVE APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 357 NORTH AMERICA: CELL EXPANSION MARKET FOR OTHER TISSUE ENGINEERING & REGENERATIVE APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 358 EUROPE: CELL EXPANSION MARKET FOR OTHER TISSUE ENGINEERING & REGENERATIVE APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 359 ASIA PACIFIC: CELL EXPANSION MARKET FOR OTHER TISSUE ENGINEERING & REGENERATIVE APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 360 LATIN AMERICA: CELL EXPANSION MARKET FOR OTHER TISSUE ENGINEERING & REGENERATIVE APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 361 MIDDLE EAST: CELL EXPANSION MARKET FOR OTHER TISSUE ENGINEERING & REGENERATIVE APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 362 GCC COUNTRIES: CELL EXPANSION MARKET FOR OTHER TISSUE ENGINEERING & REGENERATIVE APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 363 CELL EXPANSION MARKET FOR DRUG SCREENING & DEVELOPMENT, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 364 NORTH AMERICA: CELL EXPANSION MARKET FOR DRUG SCREENING & DEVELOPMENT, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 365 EUROPE: CELL EXPANSION MARKET FOR DRUG SCREENING & DEVELOPMENT, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 366 ASIA PACIFIC: CELL EXPANSION MARKET FOR DRUG SCREENING & DEVELOPMENT, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 367 LATIN AMERICA: CELL EXPANSION MARKET FOR DRUG SCREENING & DEVELOPMENT, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 368 MIDDLE EAST: CELL EXPANSION MARKET FOR DRUG SCREENING & DEVELOPMENT, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 369 GCC COUNTRIES: CELL EXPANSION MARKET FOR DRUG SCREENING & DEVELOPMENT, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 370 CELL EXPANSION MARKET FOR OTHER APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 371 NORTH AMERICA: CELL EXPANSION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 372 EUROPE: CELL EXPANSION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 373 ASIA PACIFIC: CELL EXPANSION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 374 LATIN AMERICA: CELL EXPANSION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 375 MIDDLE EAST: CELL EXPANSION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 376 GCC COUNTRIES: CELL EXPANSION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 377 CELL EXPANSION MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 378 CELL EXPANSION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 379 NORTH AMERICA: CELL EXPANSION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 380 EUROPE: CELL EXPANSION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 381 ASIA PACIFIC: CELL EXPANSION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 382 LATIN AMERICA: CELL EXPANSION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 383 MIDDLE EAST: CELL EXPANSION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 384 GCC COUNTRIES: CELL EXPANSION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 385 CELL EXPANSION MARKET FOR RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 386 NORTH AMERICA: CELL EXPANSION MARKET FOR RESEARCH & ACADEMIC INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 387 EUROPE: CELL EXPANSION MARKET FOR RESEARCH & ACADEMIC INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 388 ASIA PACIFIC: CELL EXPANSION MARKET FOR RESEARCH & ACADEMIC INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 389 LATIN AMERICA: CELL EXPANSION MARKET FOR RESEARCH & ACADEMIC INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 390 MIDDLE EAST: CELL EXPANSION MARKET FOR RESEARCH & ACADEMIC INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 391 GCC COUNTRIES: CELL EXPANSION MARKET FOR RESEARCH & ACADEMIC INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 392 CELL EXPANSION MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 393 NORTH AMERICA: CELL EXPANSION MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 394 EUROPE: CELL EXPANSION MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 395 ASIA PACIFIC: CELL EXPANSION MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 396 LATIN AMERICA: CELL EXPANSION MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 397 MIDDLE EAST: CELL EXPANSION MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 398 GCC COUNTRIES: CELL EXPANSION MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 399 CELL EXPANSION MARKET FOR OTHER END USERS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 400 NORTH AMERICA: CELL EXPANSION MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 401 EUROPE: CELL EXPANSION MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 402 ASIA PACIFIC: CELL EXPANSION MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 403 LATIN AMERICA: CELL EXPANSION MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 404 MIDDLE EAST: CELL EXPANSION MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 405 GCC COUNTRIES: CELL EXPANSION MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 406 CELL EXPANSION MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 407 NORTH AMERICA: CELL EXPANSION MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 408 NORTH AMERICA: CELL EXPANSION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 409 NORTH AMERICA: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 410 NORTH AMERICA: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 411 NORTH AMERICA: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 412 NORTH AMERICA: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 413 NORTH AMERICA: BIOREACTORS MARKET, BY USAGE, 2022–2029 (USD MILLION)
  • TABLE 414 NORTH AMERICA: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 415 NORTH AMERICA: CELL EXPANSION MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
  • TABLE 416 NORTH AMERICA: CELL EXPANSION MARKET FOR HUMAN CELLS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 417 NORTH AMERICA: CELL EXPANSION MARKET FOR STEM CELLS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 418 NORTH AMERICA: CELL EXPANSION MARKET FOR ANIMAL CELLS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 419 NORTH AMERICA: CELL EXPANSION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 420 NORTH AMERICA: CELL EXPANSION MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 421 NORTH AMERICA: CELL EXPANSION MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 422 NORTH AMERICA: CELL EXPANSION MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 423 US: CELL & GENE THERAPY APPROVALS, 2022
  • TABLE 424 US: CELL EXPANSION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 425 US: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 426 US: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 427 US: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 428 US: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 429 US: BIOREACTORS MARKET, BY USAGE, 2022–2029 (USD MILLION)
  • TABLE 430 US: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 431 US: CELL EXPANSION MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
  • TABLE 432 US: CELL EXPANSION MARKET FOR HUMAN CELLS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 433 US: CELL EXPANSION MARKET FOR STEM CELLS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 434 US: CELL EXPANSION MARKET FOR ANIMAL CELLS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 435 US: CELL EXPANSION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 436 US: CELL EXPANSION MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 437 US: CELL EXPANSION MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 438 US: CELL EXPANSION MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 439 CANADA: CELL EXPANSION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 440 CANADA: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 441 CANADA: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 442 CANADA: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 443 CANADA: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 444 CANADA: BIOREACTORS MARKET, BY USAGE, 2022–2029 (USD MILLION)
  • TABLE 445 CANADA: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 446 CANADA: CELL EXPANSION MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
  • TABLE 447 CANADA: CELL EXPANSION MARKET FOR HUMAN CELLS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 448 CANADA: CELL EXPANSION MARKET FOR STEM CELLS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 449 CANADA: CELL EXPANSION MARKET FOR ANIMAL CELLS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 450 CANADA: CELL EXPANSION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 451 CANADA: CELL EXPANSION MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 452 CANADA: CELL EXPANSION MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 453 CANADA: CELL EXPANSION MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 454 EUROPE: NEW CELL THERAPY APPROVALS, 2022
  • TABLE 455 EUROPE: CELL EXPANSION MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 456 EUROPE: CELL EXPANSION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 457 EUROPE: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 458 EUROPE: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 459 EUROPE: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 460 EUROPE: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 461 EUROPE: BIOREACTORS MARKET, BY USAGE, 2022–2029 (USD MILLION)
  • TABLE 462 EUROPE: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 463 EUROPE: CELL EXPANSION MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
  • TABLE 464 EUROPE: CELL EXPANSION MARKET FOR HUMAN CELLS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 465 EUROPE: CELL EXPANSION MARKET FOR STEM CELLS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 466 EUROPE: CELL EXPANSION MARKET FOR ANIMAL CELLS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 467 EUROPE: CELL EXPANSION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 468 EUROPE: CELL EXPANSION MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 469 EUROPE: CELL EXPANSION MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 470 EUROPE: CELL EXPANSION MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 471 GERMANY: CELL EXPANSION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 472 GERMANY: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 473 GERMANY: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 474 GERMANY: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 475 GERMANY: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 476 GERMANY: BIOREACTORS MARKET, BY USAGE, 2022–2029 (USD MILLION)
  • TABLE 477 GERMANY: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 478 GERMANY: CELL EXPANSION MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
  • TABLE 479 GERMANY: CELL EXPANSION MARKET FOR HUMAN CELLS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 480 GERMANY: CELL EXPANSION MARKET FOR STEM CELLS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 481 GERMANY: CELL EXPANSION MARKET FOR ANIMAL CELLS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 482 GERMANY: CELL EXPANSION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 483 GERMANY: CELL EXPANSION MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 484 GERMANY: CELL EXPANSION MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 485 GERMANY: CELL EXPANSION MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 486 UK: CELL EXPANSION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 487 UK: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 488 UK: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 489 UK: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 490 UK: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 491 UK: BIOREACTORS MARKET, BY USAGE, 2022–2029 (USD MILLION)
  • TABLE 492 UK: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 493 UK: CELL EXPANSION MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
  • TABLE 494 UK: CELL EXPANSION MARKET FOR HUMAN CELLS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 495 UK: CELL EXPANSION MARKET FOR STEM CELLS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 496 UK: CELL EXPANSION MARKET FOR ANIMAL CELLS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 497 UK: CELL EXPANSION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 498 UK: CELL EXPANSION MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 499 UK: CELL EXPANSION MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 500 UK: CELL EXPANSION MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 501 FRANCE: CELL EXPANSION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 502 FRANCE: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 503 FRANCE: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 504 FRANCE: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 505 FRANCE: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 506 FRANCE: BIOREACTORS MARKET, BY USAGE, 2022–2029 (USD MILLION)
  • TABLE 507 FRANCE: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 508 FRANCE: CELL EXPANSION MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
  • TABLE 509 FRANCE: CELL EXPANSION MARKET FOR HUMAN CELLS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 510 FRANCE: CELL EXPANSION MARKET FOR STEM CELLS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 511 FRANCE: CELL EXPANSION MARKET FOR ANIMAL CELLS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 512 FRANCE: CELL EXPANSION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 513 FRANCE: CELL EXPANSION MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 514 FRANCE: CELL EXPANSION MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 515 FRANCE: CELL EXPANSION MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 516 ITALY: CELL EXPANSION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 517 ITALY: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 518 ITALY: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 519 ITALY: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 520 ITALY: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 521 ITALY: BIOREACTORS MARKET, BY USAGE, 2022–2029 (USD MILLION)
  • TABLE 522 ITALY: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 523 ITALY: CELL EXPANSION MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
  • TABLE 524 ITALY: CELL EXPANSION MARKET FOR HUMAN CELLS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 525 ITALY: CELL EXPANSION MARKET FOR STEM CELLS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 526 ITALY: CELL EXPANSION MARKET FOR ANIMAL CELLS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 527 ITALY: CELL EXPANSION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 528 ITALY: CELL EXPANSION MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 529 ITALY: CELL EXPANSION MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 530 ITALY: CELL EXPANSION MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 531 SPAIN: CELL EXPANSION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 532 SPAIN: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 533 SPAIN: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 534 SPAIN: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 535 SPAIN: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 536 SPAIN: BIOREACTORS MARKET, BY USAGE, 2022–2029 (USD MILLION)
  • TABLE 537 SPAIN: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 538 SPAIN: CELL EXPANSION MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
  • TABLE 539 SPAIN: CELL EXPANSION MARKET FOR HUMAN CELLS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 540 SPAIN: CELL EXPANSION MARKET FOR STEM CELLS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 541 SPAIN: CELL EXPANSION MARKET FOR ANIMAL CELLS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 542 SPAIN: CELL EXPANSION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 543 SPAIN: CELL EXPANSION MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 544 SPAIN: CELL EXPANSION MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 545 SPAIN: CELL EXPANSION MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 546 REST OF EUROPE: CELL EXPANSION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 547 REST OF EUROPE: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 548 REST OF EUROPE: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 549 REST OF EUROPE: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 550 REST OF EUROPE: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 551 REST OF EUROPE: BIOREACTORS MARKET, BY USAGE, 2022–2029 (USD MILLION)
  • TABLE 552 REST OF EUROPE: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 553 REST OF EUROPE: CELL EXPANSION MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
  • TABLE 554 REST OF EUROPE: CELL EXPANSION MARKET FOR HUMAN CELLS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 555 REST OF EUROPE: CELL EXPANSION MARKET FOR STEM CELLS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 556 REST OF EUROPE: CELL EXPANSION MARKET FOR ANIMAL CELLS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 557 REST OF EUROPE: CELL EXPANSION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 558 REST OF EUROPE: CELL EXPANSION MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 559 REST OF EUROPE: CELL EXPANSION MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 560 REST OF EUROPE: CELL EXPANSION MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 561 ASIA PACIFIC: CELL EXPANSION MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 562 ASIA PACIFIC: CELL EXPANSION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 563 ASIA PACIFIC: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 564 ASIA PACIFIC: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 565 ASIA PACIFIC: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 566 ASIA PACIFIC: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 567 ASIA PACIFIC: BIOREACTORS MARKET, BY USAGE, 2022–2029 (USD MILLION)
  • TABLE 568 ASIA PACIFIC: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 569 ASIA PACIFIC: CELL EXPANSION MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
  • TABLE 570 ASIA PACIFIC: CELL EXPANSION MARKET FOR HUMAN CELLS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 571 ASIA PACIFIC: CELL EXPANSION MARKET FOR STEM CELLS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 572 ASIA PACIFIC: CELL EXPANSION MARKET FOR ANIMAL CELLS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 573 ASIA PACIFIC: CELL EXPANSION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 574 ASIA PACIFIC: CELL EXPANSION MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 575 ASIA PACIFIC: CELL EXPANSION MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 576 ASIA PACIFIC: CELL EXPANSION MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 577 CHINA: CELL EXPANSION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 578 CHINA: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 579 CHINA: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 580 CHINA: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 581 CHINA: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 582 CHINA: BIOREACTORS MARKET, BY USAGE, 2022–2029 (USD MILLION)
  • TABLE 583 CHINA: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 584 CHINA: CELL EXPANSION MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
  • TABLE 585 CHINA: CELL EXPANSION MARKET FOR HUMAN CELLS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 586 CHINA: CELL EXPANSION MARKET FOR STEM CELLS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 587 CHINA: CELL EXPANSION MARKET FOR ANIMAL CELLS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 588 CHINA: CELL EXPANSION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 589 CHINA: CELL EXPANSION MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 590 CHINA: CELL EXPANSION MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 591 CHINA: CELL EXPANSION MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 592 JAPAN: CELL EXPANSION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 593 JAPAN: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 594 JAPAN: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 595 JAPAN: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 596 JAPAN: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 597 JAPAN: BIOREACTORS MARKET, BY USAGE, 2022–2029 (USD MILLION)
  • TABLE 598 JAPAN: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 599 JAPAN: CELL EXPANSION MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
  • TABLE 600 JAPAN: CELL EXPANSION MARKET FOR HUMAN CELLS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 601 JAPAN: CELL EXPANSION MARKET FOR STEM CELLS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 602 JAPAN: CELL EXPANSION MARKET FOR ANIMAL CELLS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 603 JAPAN: CELL EXPANSION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 604 JAPAN: CELL EXPANSION MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 605 JAPAN: CELL EXPANSION MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 606 JAPAN: CELL EXPANSION MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 607 INDIA: CELL EXPANSION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 608 INDIA: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 609 INDIA: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 610 INDIA: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 611 INDIA: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 612 INDIA: BIOREACTORS MARKET, BY USAGE, 2022–2029 (USD MILLION)
  • TABLE 613 INDIA: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 614 INDIA: CELL EXPANSION MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
  • TABLE 615 INDIA: CELL EXPANSION MARKET FOR HUMAN CELLS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 616 INDIA: CELL EXPANSION MARKET FOR STEM CELLS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 617 INDIA: CELL EXPANSION MARKET FOR ANIMAL CELLS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 618 INDIA: CELL EXPANSION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 619 INDIA: CELL EXPANSION MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 620 INDIA: CELL EXPANSION MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 621 INDIA: CELL EXPANSION MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 622 SOUTH KOREA: CELL EXPANSION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 623 SOUTH KOREA: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 624 SOUTH KOREA: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 625 SOUTH KOREA: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 626 SOUTH KOREA: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 627 SOUTH KOREA: BIOREACTORS MARKET, BY USAGE, 2022–2029 (USD MILLION)
  • TABLE 628 SOUTH KOREA: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 629 SOUTH KOREA: CELL EXPANSION MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
  • TABLE 630 SOUTH KOREA: CELL EXPANSION MARKET FOR HUMAN CELLS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 631 SOUTH KOREA: CELL EXPANSION MARKET FOR STEM CELLS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 632 SOUTH KOREA: CELL EXPANSION MARKET FOR ANIMAL CELLS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 633 SOUTH KOREA: CELL EXPANSION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 634 SOUTH KOREA: CELL EXPANSION MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 635 SOUTH KOREA: CELL EXPANSION MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 636 SOUTH KOREA: CELL EXPANSION MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 637 AUSTRALIA: CELL EXPANSION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 638 AUSTRALIA: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 639 AUSTRALIA: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 640 AUSTRALIA: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 641 AUSTRALIA: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 642 AUSTRALIA: BIOREACTORS MARKET, BY USAGE, 2022–2029 (USD MILLION)
  • TABLE 643 AUSTRALIA: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 644 AUSTRALIA: CELL EXPANSION MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
  • TABLE 645 AUSTRALIA: CELL EXPANSION MARKET FOR HUMAN CELLS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 646 AUSTRALIA: CELL EXPANSION MARKET FOR STEM CELLS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 647 AUSTRALIA: CELL EXPANSION MARKET FOR ANIMAL CELLS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 648 AUSTRALIA: CELL EXPANSION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 649 AUSTRALIA: CELL EXPANSION MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 650 AUSTRALIA: CELL EXPANSION MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 651 AUSTRALIA: CELL EXPANSION MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 652 REST OF ASIA PACIFIC: CELL EXPANSION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 653 REST OF ASIA PACIFIC: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 654 REST OF ASIA PACIFIC: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 655 REST OF ASIA PACIFIC: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 656 REST OF ASIA PACIFIC: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 657 REST OF ASIA PACIFIC: BIOREACTORS MARKET, BY USAGE, 2022–2029 (USD MILLION)
  • TABLE 658 REST OF ASIA PACIFIC: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 659 REST OF ASIA PACIFIC: CELL EXPANSION MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
  • TABLE 660 REST OF ASIA PACIFIC: CELL EXPANSION MARKET FOR HUMAN CELLS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 661 REST OF ASIA PACIFIC: CELL EXPANSION MARKET FOR STEM CELLS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 662 REST OF ASIA PACIFIC: CELL EXPANSION MARKET FOR ANIMAL CELLS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 663 REST OF ASIA PACIFIC: CELL EXPANSION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 664 REST OF ASIA PACIFIC: CELL EXPANSION MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 665 REST OF ASIA PACIFIC: CELL EXPANSION MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 666 REST OF ASIA PACIFIC: CELL EXPANSION MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 667 LATIN AMERICA: CELL EXPANSION MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 668 LATIN AMERICA: CELL EXPANSION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 669 LATIN AMERICA: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 670 LATIN AMERICA: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 671 LATIN AMERICA: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 672 LATIN AMERICA: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 673 LATIN AMERICA: BIOREACTORS MARKET, BY USAGE, 2022–2029 (USD MILLION)
  • TABLE 674 LATIN AMERICA: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 675 LATIN AMERICA: CELL EXPANSION MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
  • TABLE 676 LATIN AMERICA: CELL EXPANSION MARKET FOR HUMAN CELLS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 677 LATIN AMERICA: CELL EXPANSION MARKET FOR STEM CELLS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 678 LATIN AMERICA: CELL EXPANSION MARKET FOR ANIMAL CELLS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 679 LATIN AMERICA: CELL EXPANSION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 680 LATIN AMERICA: CELL EXPANSION MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 681 LATIN AMERICA: CELL EXPANSION MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 682 LATIN AMERICA: CELL EXPANSION MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 683 BRAZIL: CELL EXPANSION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 684 BRAZIL: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 685 BRAZIL: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 686 BRAZIL: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 687 BRAZIL: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 688 BRAZIL: BIOREACTORS MARKET, BY USAGE, 2022–2029 (USD MILLION)
  • TABLE 689 BRAZIL: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 690 BRAZIL: CELL EXPANSION MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
  • TABLE 691 BRAZIL: CELL EXPANSION MARKET FOR HUMAN CELLS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 692 BRAZIL: CELL EXPANSION MARKET FOR STEM CELLS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 693 BRAZIL: CELL EXPANSION MARKET FOR ANIMAL CELLS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 694 BRAZIL: CELL EXPANSION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 695 BRAZIL: CELL EXPANSION MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 696 BRAZIL: CELL EXPANSION MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 697 BRAZIL: CELL EXPANSION MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 698 MEXICO: CELL EXPANSION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 699 MEXICO: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 700 MEXICO: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 701 MEXICO: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 702 MEXICO: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 703 MEXICO: BIOREACTORS MARKET, BY USAGE, 2022–2029 (USD MILLION)
  • TABLE 704 MEXICO: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 705 MEXICO: CELL EXPANSION MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
  • TABLE 706 MEXICO: CELL EXPANSION MARKET FOR HUMAN CELLS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 707 MEXICO: CELL EXPANSION MARKET FOR STEM CELLS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 708 MEXICO: CELL EXPANSION MARKET FOR ANIMAL CELLS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 709 MEXICO: CELL EXPANSION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 710 MEXICO: CELL EXPANSION MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 711 MEXICO: CELL EXPANSION MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 712 MEXICO: CELL EXPANSION MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 713 REST OF LATIN AMERICA: CELL EXPANSION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 714 REST OF LATIN AMERICA: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 715 REST OF LATIN AMERICA: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 716 REST OF LATIN AMERICA: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 717 REST OF LATIN AMERICA: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 718 REST OF LATIN AMERICA: BIOREACTORS MARKET, BY USAGE, 2022–2029 (USD MILLION)
  • TABLE 719 REST OF LATIN AMERICA: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 720 REST OF LATIN AMERICA: CELL EXPANSION MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
  • TABLE 721 REST OF LATIN AMERICA: CELL EXPANSION MARKET FOR HUMAN CELLS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 722 REST OF LATIN AMERICA: CELL EXPANSION MARKET FOR STEM CELLS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 723 REST OF LATIN AMERICA: CELL EXPANSION MARKET FOR ANIMAL CELLS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 724 REST OF LATIN AMERICA: CELL EXPANSION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 725 REST OF LATIN AMERICA: CELL EXPANSION MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 726 REST OF LATIN AMERICA: CELL EXPANSION MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 727 REST OF LATIN AMERICA: CELL EXPANSION MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 728 MIDDLE EAST: CELL EXPANSION MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 729 MIDDLE EAST: CELL EXPANSION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 730 MIDDLE EAST: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 731 MIDDLE EAST: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 732 MIDDLE EAST: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 733 MIDDLE EAST: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 734 MIDDLE EAST: BIOREACTORS MARKET, BY USAGE, 2022–2029 (USD MILLION)
  • TABLE 735 MIDDLE EAST: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 736 MIDDLE EAST: CELL EXPANSION MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
  • TABLE 737 MIDDLE EAST: CELL EXPANSION MARKET FOR HUMAN CELLS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 738 MIDDLE EAST: CELL EXPANSION MARKET FOR STEM CELLS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 739 MIDDLE EAST: CELL EXPANSION MARKET FOR ANIMAL CELLS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 740 MIDDLE EAST: CELL EXPANSION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 741 MIDDLE EAST: CELL EXPANSION MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 742 MIDDLE EAST: CELL EXPANSION MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 743 MIDDLE EAST: CELL EXPANSION MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 744 GCC COUNTRIES: CELL EXPANSION MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 745 GCC COUNTRIES: CELL EXPANSION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 746 GCC COUNTRIES: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 747 GCC COUNTRIES: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 748 GCC COUNTRIES: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 749 GCC COUNTRIES: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 750 GCC COUNTRIES: BIOREACTORS MARKET, BY USAGE, 2022–2029 (USD MILLION)
  • TABLE 751 GCC COUNTRIES: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 752 GCC COUNTRIES: CELL EXPANSION MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
  • TABLE 753 GCC COUNTRIES: CELL EXPANSION MARKET FOR HUMAN CELLS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 754 GCC COUNTRIES: CELL EXPANSION MARKET FOR STEM CELLS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 755 GCC COUNTRIES: CELL EXPANSION MARKET FOR ANIMAL CELLS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 756 GCC COUNTRIES: CELL EXPANSION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 757 GCC COUNTRIES: CELL EXPANSION MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 758 GCC COUNTRIES: CELL EXPANSION MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 759 GCC COUNTRIES: CELL EXPANSION MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 760 SAUDI ARABIA: CELL EXPANSION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 761 SAUDI ARABIA: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 762 SAUDI ARABIA: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 763 SAUDI ARABIA: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 764 SAUDI ARABIA: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 765 SAUDI ARABIA: BIOREACTORS MARKET, BY USAGE, 2022–2029 (USD MILLION)
  • TABLE 766 SAUDI ARABIA: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 767 SAUDI ARABIA: CELL EXPANSION MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
  • TABLE 768 SAUDI ARABIA: CELL EXPANSION MARKET FOR HUMAN CELLS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 769 SAUDI ARABIA: CELL EXPANSION MARKET FOR STEM CELLS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 770 SAUDI ARABIA: CELL EXPANSION MARKET FOR ANIMAL CELLS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 771 SAUDI ARABIA: CELL EXPANSION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 772 SAUDI ARABIA: CELL EXPANSION MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 773 SAUDI ARABIA: CELL EXPANSION MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 774 SAUDI ARABIA: CELL EXPANSION MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 775 UNITED ARAB EMIRATES: CELL EXPANSION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 776 UNITED ARAB EMIRATES: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 777 UNITED ARAB EMIRATES: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 778 UNITED ARAB EMIRATES: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 779 UNITED ARAB EMIRATES: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 780 UNITED ARAB EMIRATES: BIOREACTORS MARKET, BY USAGE, 2022–2029 (USD MILLION)
  • TABLE 781 UNITED ARAB EMIRATES: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 782 UNITED ARAB EMIRATES: CELL EXPANSION MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
  • TABLE 783 UNITED ARAB EMIRATES: CELL EXPANSION MARKET FOR HUMAN CELLS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 784 UNITED ARAB EMIRATES: CELL EXPANSION MARKET FOR STEM CELLS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 785 UNITED ARAB EMIRATES: CELL EXPANSION MARKET FOR ANIMAL CELLS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 786 UNITED ARAB EMIRATES: CELL EXPANSION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 787 UNITED ARAB EMIRATES: CELL EXPANSION MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 788 UNITED ARAB EMIRATES: CELL EXPANSION MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 789 UNITED ARAB EMIRATES: CELL EXPANSION MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 790 REST OF GCC COUNTRIES: CELL EXPANSION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 791 REST OF GCC COUNTRIES: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 792 REST OF GCC COUNTRIES: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 793 REST OF GCC COUNTRIES: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 794 REST OF GCC COUNTRIES: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 795 REST OF GCC COUNTRIES: BIOREACTORS MARKET, BY USAGE, 2022–2029 (USD MILLION)
  • TABLE 796 REST OF GCC COUNTRIES: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 797 REST OF GCC COUNTRIES: CELL EXPANSION MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
  • TABLE 798 REST OF GCC COUNTRIES: CELL EXPANSION MARKET FOR HUMAN CELLS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 799 REST OF GCC COUNTRIES: CELL EXPANSION MARKET FOR STEM CELLS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 800 REST OF GCC COUNTRIES: CELL EXPANSION MARKET FOR ANIMAL CELLS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 801 REST OF GCC COUNTRIES: CELL EXPANSION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 802 REST OF GCC COUNTRIES: CELL EXPANSION MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 803 REST OF GCC COUNTRIES: CELL EXPANSION MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 804 REST OF GCC COUNTRIES: CELL EXPANSION MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 805 REST OF MIDDLE EAST: CELL EXPANSION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 806 REST OF MIDDLE EAST: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 807 REST OF MIDDLE EAST: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 808 REST OF MIDDLE EAST: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 809 REST OF MIDDLE EAST: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 810 REST OF MIDDLE EAST: BIOREACTORS MARKET, BY USAGE, 2022–2029 (USD MILLION)
  • TABLE 811 REST OF MIDDLE EAST: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 812 REST OF MIDDLE EAST: CELL EXPANSION MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
  • TABLE 813 REST OF MIDDLE EAST: CELL EXPANSION MARKET FOR HUMAN CELLS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 814 REST OF MIDDLE EAST: CELL EXPANSION MARKET FOR STEM CELLS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 815 REST OF MIDDLE EAST: CELL EXPANSION MARKET FOR ANIMAL CELLS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 816 REST OF MIDDLE EAST: CELL EXPANSION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 817 REST OF MIDDLE EAST: CELL EXPANSION MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 818 REST OF MIDDLE EAST: CELL EXPANSION MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 819 REST OF MIDDLE EAST: CELL EXPANSION MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 820 AFRICA: CELL EXPANSION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 821 AFRICA: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 822 AFRICA: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 823 AFRICA: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 824 AFRICA: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 825 AFRICA: BIOREACTORS MARKET, BY USAGE, 2022–2029 (USD MILLION)
  • TABLE 826 AFRICA: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 827 AFRICA: CELL EXPANSION MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
  • TABLE 828 AFRICA: CELL EXPANSION MARKET FOR HUMAN CELLS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 829 AFRICA: CELL EXPANSION MARKET FOR STEM CELLS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 830 AFRICA: CELL EXPANSION MARKET FOR ANIMAL CELLS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 831 AFRICA: CELL EXPANSION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 832 AFRICA: CELL EXPANSION MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 833 AFRICA: CELL EXPANSION MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 834 AFRICA: CELL EXPANSION MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 835 STRATEGIES ADOPTED BY KEY PLAYERS IN CELL EXPANSION MARKET, 2021–2024
  • TABLE 836 CELL EXPANSION MARKET: DEGREE OF COMPETITION
  • TABLE 837 CELL EXPANSION MARKET: REGIONAL FOOTPRINT
  • TABLE 838 CELL EXPANSION MARKET: PRODUCT FOOTPRINT
  • TABLE 839 CELL EXPANSION MARKET: APPLICATION FOOTPRINT
  • TABLE 840 CELL EXPANSION MARKET: END-USER FOOTPRINT
  • TABLE 841 CELL EXPANSION MARKET: DETAILED LIST OF KEY STARTUPS/SMES
  • TABLE 842 CELL EXPANSION MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/ SMES, 2023
  • TABLE 843 CELL EXPANSION MARKET: PRODUCT LAUNCHES, JANUARY 2021–JANUARY 2024
  • TABLE 844 CELL EXPANSION MARKET: DEALS, JANUARY 2021–JANUARY 2024
  • TABLE 845 CELL EXPANSION MARKET: EXPANSIONS, JANUARY 2021–JANUARY 2024
  • TABLE 846 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
  • TABLE 847 THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED
  • TABLE 848 THERMO FISHER SCIENTIFIC INC.: PRODUCT LAUNCHES
  • TABLE 849 THERMO FISHER SCIENTIFIC INC.: DEALS
  • TABLE 850 THERMO FISHER SCIENTIFIC INC.: EXPANSIONS
  • TABLE 851 DANAHER CORPORATION: COMPANY OVERVIEW
  • TABLE 852 DANAHER CORPORATION: PRODUCTS OFFERED
  • TABLE 853 DANAHER CORPORATION: PRODUCT LAUNCHES
  • TABLE 854 DANAHER CORPORATION: DEALS
  • TABLE 855 DANAHER CORPORATION: EXPANSIONS
  • TABLE 856 DANAHER CORPORATION: OTHER DEVELOPMENTS
  • TABLE 857 MERCK KGAA: COMPANY OVERVIEW
  • TABLE 858 MERCK KGAA: PRODUCTS OFFERED
  • TABLE 859 MERCK KGAA: DEALS
  • TABLE 860 MERCK KGAA: EXPANSIONS
  • TABLE 861 SARTORIUS AG: COMPANY OVERVIEW
  • TABLE 862 SARTORIUS AG: PRODUCTS OFFERED
  • TABLE 863 SARTORIUS AG: DEALS
  • TABLE 864 SARTORIUS AG: EXPANSIONS
  • TABLE 865 CORNING INCORPORATED: COMPANY OVERVIEW
  • TABLE 866 CORNING INCORPORATED: PRODUCTS OFFERED
  • TABLE 867 CORNING INCORPORATED: PRODUCT LAUNCHES
  • TABLE 868 CORNING INCORPORATED: DEALS
  • TABLE 869 LONZA: COMPANY OVERVIEW
  • TABLE 870 LONZA: PRODUCTS OFFERED
  • TABLE 871 LONZA: PRODUCT LAUNCHES
  • TABLE 872 LONZA: DEALS
  • TABLE 873 LONZA: EXPANSIONS
  • TABLE 874 TERUMO CORPORATION: COMPANY OVERVIEW
  • TABLE 875 TERUMO CORPORATION: PRODUCTS OFFERED
  • TABLE 876 TERUMO CORPORATION: PRODUCT LAUNCHES
  • TABLE 877 TERUMO CORPORATION: DEALS
  • TABLE 878 EPPENDORF SE: COMPANY OVERVIEW
  • TABLE 879 EPPENDORF SE: PRODUCTS OFFERED
  • TABLE 880 EPPENDORF SE: PRODUCT LAUNCHES
  • TABLE 881 EPPENDORF SE: EXPANSIONS
  • TABLE 882 FUJIFILM CORPORATION: COMPANY OVERVIEW
  • TABLE 883 FUJIFILM CORPORATION: PRODUCTS OFFERED
  • TABLE 884 FUJIFILM CORPORATION: PRODUCT LAUNCHES
  • TABLE 885 FUJIFILM CORPORATION: DEALS
  • TABLE 886 FUJIFILM CORPORATION: EXPANSIONS
  • TABLE 887 BIO-TECHNE: COMPANY OVERVIEW
  • TABLE 888 BIO-TECHNE: PRODUCTS OFFERED
  • TABLE 889 BIO-TECHNE: PRODUCT LAUNCHES
  • TABLE 890 BIO-TECHNE: DEALS
  • TABLE 891 REPLIGEN CORPORATION: COMPANY OVERVIEW
  • TABLE 892 REPLIGEN CORPORATION: PRODUCTS OFFERED
  • TABLE 893 REPLIGEN CORPORATION: DEALS
  • TABLE 894 GETINGE AB: COMPANY OVERVIEW
  • TABLE 895 GETINGE AB: PRODUCTS OFFERED
  • TABLE 896 GETINGE AB: PRODUCT LAUNCHES
  • TABLE 897 GETINGE AB: DEALS
  • TABLE 898 BD: BUSINESS OVERVIEW
  • TABLE 899 BD: PRODUCTS OFFERED
  • TABLE 900 MILTENYI BIOTEC: COMPANY OVERVIEW
  • TABLE 901 MILTENYI BIOTEC: PRODUCTS OFFERED
  • TABLE 902 MILTENYI BIOTEC: EXPANSIONS
  • TABLE 903 PERKINELMER INC.: COMPANY OVERVIEW
  • TABLE 904 PERKINELMER INC.: PRODUCTS OFFERED
  • TABLE 905 PERKINELMER INC.: DEALS
  • TABLE 906 STEMCELL TECHNOLOGIES: COMPANY OVERVIEW
  • TABLE 907 STEMCELL TECHNOLOGIES: PRODUCTS OFFERED
  • TABLE 908 STEMCELL TECHNOLOGIES: DEALS
  • TABLE 909 PROMOCELL GMBH: COMPANY OVERVIEW
  • TABLE 910 PROMOCELL GMBH: PRODUCTS OFFERED
  • TABLE 911 PROMOCELL GMBH: PRODUCT LAUNCHES
  • TABLE 912 HIMEDIA LABORATORIES: COMPANY OVERVIEW
  • TABLE 913 HIMEDIA LABORATORIES: PRODUCTS OFFERED
  • TABLE 914 TAKARA BIO INC.: BUSINESS OVERVIEW
  • TABLE 915 SHANGHAI DUONING BIOTECHNOLOGY CO., LTD.: BUSINESS OVERVIEW
  • TABLE 916 REPROCELL INC.: BUSINESS OVERVIEW
  • TABLE 917 PBS BIOTECH, INC.: BUSINESS OVERVIEW
  • TABLE 918 ACROBIOSYSTEMS: COMPANY OVERVIEW
  • TABLE 919 SOLIDA BIOTECH GMBH: BUSINESS OVERVIEW
  • TABLE 920 BEIJING CYTONICHE BIOTECHNOLOGY CO., LTD.: BUSINESS OVERVIEW
  • TABLE 921 NEUROMICS: BUSINESS OVERVIEW
  • TABLE 922 BIONET: BUSINESS OVERVIEW
  • TABLE 923 CELLEXUS: BUSINESS OVERVIEW
LIST OF FIGURES
 
  • FIGURE 1 RESEARCH DESIGN
  • FIGURE 2 BREAKDOWN OF PRIMARIES: CELL EXPANSION MARKET
  • FIGURE 3 CELL EXPANSION MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2023
  • FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2023
  • FIGURE 5 REVENUE SHARE ANALYSIS: ILLUSTRATIVE EXAMPLE OF THERMO FISHER SCIENTIFIC INC. (2023)
  • FIGURE 6 MARKET SIZE VALIDATION FROM PRIMARY SOURCES
  • FIGURE 7 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
  • FIGURE 8 CELL EXPANSION MARKET: CAGR PROJECTIONS
  • FIGURE 9 DATA TRIANGULATION METHODOLOGY
  • FIGURE 10 CELL EXPANSION MARKET, BY PRODUCT, 2024 VS. 2029 (USD MILLION)
  • FIGURE 11 CELL EXPANSION MARKET, BY CELL TYPE, 2024 VS. 2029 (USD MILLION)
  • FIGURE 12 CELL EXPANSION MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
  • FIGURE 13 CELL EXPANSION MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
  • FIGURE 14 GEOGRAPHICAL SNAPSHOT OF CELL EXPANSION MARKET
  • FIGURE 15 GROWING FOCUS ON PERSONALIZED MEDICINE TO DRIVE MARKET
  • FIGURE 16 CONSUMABLES ACCOUNTED FOR LARGEST SHARE OF ASIA PACIFIC CELL EXPANSION MARKET IN 2023
  • FIGURE 17 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
  • FIGURE 18 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES ACCOUNTED FOR LARGEST MARKET SHARE IN 2023
  • FIGURE 19 CELL EXPANSION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 20 CANCER INCIDENCE, BY REGION, 2022
  • FIGURE 21 US: PERCENTAGE OF DEATHS CAUSED BY HEART DISEASE, 2021
  • FIGURE 22 PERCENTAGE OF PERSONALIZED MEDICINES IN FDA'S NEW DRUG APPROVALS, 2015–2022
  • FIGURE 23 CELL EXPANSION MARKET: SUPPLY CHAIN ANALYSIS
  • FIGURE 24 CELL EXPANSION MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 25 CELL EXPANSION MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 26 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS
  • FIGURE 27 TOTAL NUMBER OF PATENTS GRANTED, 2014–2024
  • FIGURE 28 TOP TEN PLAYERS WITH HIGHEST NUMBER OF PATENT APPLICATIONS, 2014–2024
  • FIGURE 29 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF CELL EXPANSION PRODUCTS
  • FIGURE 30 KEY BUYING CRITERIA FOR END USERS
  • FIGURE 31 NORTH AMERICA: CELL EXPANSION MARKET SNAPSHOT
  • FIGURE 32 ASIA PACIFIC: CELL EXPANSION MARKET SNAPSHOT
  • FIGURE 33 REVENUE SHARE ANALYSIS OF KEY PLAYERS IN CELL EXPANSION MARKET, 2019–2023 (USD MILLION)
  • FIGURE 34 CELL EXPANSION MARKET SHARE ANALYSIS, BY KEY PLAYER (2023)
  • FIGURE 35 BRAND/PRODUCT COMPARATIVE ANALYSIS
  • FIGURE 36 CELL EXPANSION MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
  • FIGURE 37 CELL EXPANSION MARKET: COMPANY FOOTPRINT
  • FIGURE 38 CELL EXPANSION MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
  • FIGURE 39 EV/EBITDA OF KEY VENDORS
  • FIGURE 40 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 41 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 42 DANAHER CORPORATION: COMPANY SNAPSHOT (2023)
  • FIGURE 43 MERCK KGAA: COMPANY SNAPSHOT (2023)
  • FIGURE 44 SARTORIUS AG: COMPANY SNAPSHOT (2023)
  • FIGURE 45 CORNING INCORPORATED: COMPANY SNAPSHOT (2023)
  • FIGURE 46 LONZA: COMPANY SNAPSHOT (2023)
  • FIGURE 47 TERUMO CORPORATION: COMPANY SNAPSHOT (2022)
  • FIGURE 48 EPPENDORF SE: COMPANY SNAPSHOT (2022)
  • FIGURE 49 FUJIFILM CORPORATION: COMPANY SNAPSHOT (2022)
  • FIGURE 50 BIO-TECHNE: COMPANY SNAPSHOT (2023)
  • FIGURE 51 REPLIGEN CORPORATION: COMPANY SNAPSHOT (2023)
  • FIGURE 52 GETINGE AB: COMPANY SNAPSHOT (2022)
  • FIGURE 53 BD: COMPANY SNAPSHOT (2023)
  • FIGURE 54 PERKINELMER INC.: COMPANY SNAPSHOT (2022)

This research study involved the extensive use of secondary sources, directories, and databases to identify and collect valuable information for the analysis of the global cell expansion market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and assess the growth prospects of the market. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.

Secondary Research

Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the cell expansion market. The secondary sources used for this study include World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), National Institutes of Health (NIH), US Food and Drug Administration (FDA), South African Medical Research Council, International Society for Cell & Gene Therapy (ISCT), International Business Magazine, Nasdaq, Center for Strategic & International Studies (CSIS), American Society of Gene & Cell Therapy, Statista; corporate filings such as annual reports, SEC filings, investor presentations, and financial statements; press releases; trade, business, professional associations and among others. These sources were also used to obtain key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.

Primary Research

Extensive primary research was conducted after acquiring basic knowledge about the global cell expansion market scenario through secondary research. Several primary interviews were conducted with market experts from the demand side, such as pharmaceutical and biopharmaceutical companies, research & academic institutes, hospitals & diagnostic laboratories, CROs, and CMOs, and experts from the supply side, such as C-level and D-level executives, product managers, marketing & sales managers of key manufacturers, distributors, and channel partners. These interviews were conducted across six major regions, including the Asia Pacific, North America, Europe, Latin America, Middle East, and Africa. Approximately 60% and 40% of the primary interviews were conducted with supply-side and demand-side participants, respectively. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.

The following is a breakdown of the primary respondents:

Cell Expansion Market Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of the cell expansion market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

Bottom-up Approach

  • The key players in the industry and market have been identified through extensive secondary research
  • The revenues generated from the cell expansion business of leading players have been determined through primary and secondary research
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources

Cell Expansion Market Size, and Share

To know about the assumptions considered for the study, Request for Free Sample Report

Top-down Approach

After arriving at the overall market size from the market size estimation process, the total market was split into several segments and subsegments.

Cell Expansion Market Size, and Share

Data Triangulation

After arriving at the market size  from the market size estimation process explained above, the total market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

Market Definition

Cell expansion is a process of increasing the number of cells through cell division. Cell expansion is often used for research and therapeutic applications. Cell expansion is also used for manufacturing of cell based therapies such as tissue engineering, cell & gene therapy, and regenerative medicine.

Stakeholders

  • Cell Expansion Product Manufacturers, Vendors, and Distributors
  • Academic and Research Institutes
  • Pharmaceutical and Biotechnology Companies
  • Hospitals and Diagnostic Laboratories
  • Venture Capitalists and Investors
  • Private Research Firms
  • Contract Research Organizations (CROs)
  • Contract Development and Manufacturing Organizations (CDMOs)

Report Objectives

  • To define, describe, and forecast the global cell expansion market based on the product, cell type, application, end user, and region
  • To provide detailed information regarding the major factors influencing the growth of the market (such as drivers, restraints, opportunities and challenges)
  • To strategically analyze micro-markets with respect to individual growth trends, future prospects, and contributions to the overall cell expansion market
  • To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of the market segments with respect to six main regions, namely, North America, Europe, Asia Pacific, Latin America, Middle East, and Africa
  • To strategically profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
  • To track and analyze competitive developments such as acquisitions, product launches, expansions, and R&D activities in the cell expansion market.

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for this report:

Portfolio Assessment

  • Product Matrix, which gives a detailed comparison of the product portfolios of the top three companies.

Company Information

  • Detailed analysis and profiling of additional market players (up to three).

Geographical Analysis

  • A further breakdown of the Rest of Asia Pacific cell expansion market into countries
  • A further breakdown of the Rest of Europe  cell expansion market into countries
  • A further breakdown of the Rest of Latin American cell expansion market into countries
  • A further breakdown of the Rest of Middle East cell expansion market into countries

Previous Versions of this Report

Cell Expansion Market by Product (Reagent, Media, Flow Cytometer, Centrifuge, Bioreactor), Cell Type (Human, Animal), Application (Regenerative Medicine & Stem Cell Research, Cancer & Cell-based Research), End-User, and Region - Global Forecast to 2025

Report Code BT 2850
Published in Jun, 2020, By MarketsandMarkets™

Cell Expansion Market by Product (Reagent, Media, Flow Cytometer, Centrifuge, Bioreactor), Cell Type (Human, Animal), Application (Regenerative Medicine & Stem Cell Research, Cancer & Cell-based Research), End User, and Region - Global Forecast to 2024

Report Code BT 2850
Published in Apr, 2019, By MarketsandMarkets™

Cell Expansion Market by Product (Reagent, Media, Flow Cytometer, Centrifuge, Bioreactor), Cell Type (human, animal), Application (Regenerative Medicine & Stem Cell Research, Cancer), End user (Research Institute, Cell Bank) - Global Forecasts to 2021

Report Code BT 2850
Published in Jun, 2016, By MarketsandMarkets™

Cell Expansion Market by Product (Reagent, Media, Serum, Bioreactors, Centrifuge), Cell Type (human, animal), Application (Stem Cell Research, Regenerative Medicine, Clinical Diagnostics), End User (Hospital, Biotechnology, Cell Bank) - Forecast to 2019

Report Code BT 2850
Published in Oct, 2014, By MarketsandMarkets™
"Our USP is "providing game-changing business opportunities reports with free customization" - so please feel free to provide us with your specific areas of interest / business challenges in much greater detail !!"

We appreciate your interest in this report. Once you fill out the form, you'll be immediately directed to an exclusive solution tailored to your needs. This high-value offering can help boost your revenue by 30% - a must-see opportunity for anyone looking to maximize growth.


By clicking the "Submit" button, you are agreeing to the Terms of Use and Privacy Policy.

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

Growth opportunities and latent adjacency in Cell Expansion Market

DMCA.com Protection Status